Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Glycosylated lipoprotein]

T Hiraga1

  • 1Department of Endocrinology and Metabolism, Toranomon Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Diabetes accelerates atherosclerosis through chronic hyperglycemia, which modifies lipoproteins. Glycosylated lipoproteins and advanced glycation end products (AGEs) are key contributors to this process, increasing cardiovascular disease risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunohistochemical and functional studies for M₃ muscarinic receptors and cyclo-oxygenase-2 expressed in the mouse atrium.

Autonomic & autacoid pharmacology·2012
Same author

Preferential involvement of the basolateral limbic circuit in an amyotrophic lateral sclerosis patient.

European journal of neurology·2007
Same author

Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease.

The European respiratory journal·2007
Same author

Hedgehog and Fgf signaling pathways regulate the development of tphR-expressing serotonergic raphe neurons in zebrafish embryos.

Journal of neurobiology·2004
Same author

Near-field optical microscope observation of dye-containing nano-domains.

Journal of microscopy·2004
Same author

Melt segregation and strain partitioning: implications for seismic anisotropy and mantle flow.

Science (New York, N.Y.)·2003

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Research

Context:

  • Diabetes mellitus is a major risk factor for cardiovascular diseases, including coronary heart disease, cerebrovascular disease, and peripheral vascular disease.
  • Chronic hyperglycemia in diabetes alters various circulating substances, notably lipoproteins.
  • Glycosylated lipoproteins are implicated in the accelerated progression of atherosclerosis.

Purpose:

  • To review existing literature on the role of glycosylated lipoproteins in atherosclerosis.
  • To discuss the potential contribution of advanced glycation end products (AGEs) to atherogenesis in diabetic patients.

Summary:

  • This review synthesizes evidence highlighting the significance of glycosylated lipoproteins in the development and progression of atherosclerosis.

Related Experiment Videos

  • It explores how chronic hyperglycemia, a hallmark of diabetes, leads to lipoprotein modification.
  • The role of advanced glycation end products (AGEs) in diabetes-related atherogenesis is also examined.

    • Impact:

    • Provides a comprehensive overview of the mechanisms linking diabetes to cardiovascular complications via lipoprotein modification.
    • Highlights glycosylated lipoproteins and AGEs as critical targets for understanding and potentially mitigating diabetic cardiovascular disease.
    • Informs future research directions for preventing and treating atherosclerosis in diabetic populations.